Literature DB >> 21622233

The DFNB1 subtype of autosomal recessive non-syndromic hearing impairment.

Francisco J del Castillo1, Ignacio del Castillo.   

Abstract

Inherited hearing impairment is a frequent and highly heterogeneous condition. Among the different subtypes of autosomal recessive non-syndromic hearing impairment, DFNB1 is remarkable for its high frequency in most populations. It is caused by mutations in the coding region or splice-sites of the GJB2 gene, or by mutations affecting regulatory sequences that are essential for the expression of this gene. GJB2 encodes connexin-26, a protein component of intercellular gap junctions, which play crucial physiological roles in the cochlea. Because of its high frequency, DFNB1 hearing impairment has received continued attention from researchers along the years, resulting in a wealth of data that is unparalleled among these disorders. Here we review our current knowledge on the genetic, molecular, and phenotypic aspects of this subtype of hearing impairment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622233     DOI: 10.2741/3910

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  28 in total

1.  Pannexin 1 deficiency can induce hearing loss.

Authors:  Hong-Bo Zhao; Yan Zhu; Chun Liang; Jin Chen
Journal:  Biochem Biophys Res Commun       Date:  2015-05-20       Impact factor: 3.575

2.  A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: Reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall.

Authors:  Ling Mei; Jin Chen; Liang Zong; Yan Zhu; Chun Liang; Raleigh O Jones; Hong-Bo Zhao
Journal:  Neurobiol Dis       Date:  2017-08-17       Impact factor: 5.996

3.  Cell degeneration is not a primary causer for Connexin26 (GJB2) deficiency associated hearing loss.

Authors:  Chun Liang; Yan Zhu; Liang Zong; Guang-Jin Lu; Hong-Bo Zhao
Journal:  Neurosci Lett       Date:  2012-09-11       Impact factor: 3.046

4.  Understanding of the molecular evolution of deafness-associated pathogenic mutations of connexin 26.

Authors:  Xin-Huan Han; Yi Fan; Qin-Jun Wei; Guang-Qian Xing; Xin Cao
Journal:  Genetica       Date:  2014-12-02       Impact factor: 1.082

5.  Progressive age-dependence and frequency difference in the effect of gap junctions on active cochlear amplification and hearing.

Authors:  Liang Zong; Jin Chen; Yan Zhu; Hong-Bo Zhao
Journal:  Biochem Biophys Res Commun       Date:  2017-05-25       Impact factor: 3.575

6.  The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.

Authors:  Pallavi V Mhaske; Noah A Levit; Leping Li; Hong-Zhan Wang; Jack R Lee; Zunaira Shuja; Peter R Brink; Thomas W White
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-27       Impact factor: 4.249

7.  The pathological effects of connexin 26 variants related to hearing loss by in silico and in vitro analysis.

Authors:  Hui Ram Kim; Se-Kyung Oh; Eun-Shil Lee; Soo-Young Choi; Seung-Eon Roh; Sang Jeong Kim; Tomitake Tsukihara; Kyu-Yup Lee; Chang-Jin Jeon; Un-Kyung Kim
Journal:  Hum Genet       Date:  2016-01-09       Impact factor: 4.132

8.  Identification of D179H, a novel missense GJB2 mutation in a western Sicily family.

Authors:  Caterina Bartolotta; Pietro Salvago; Salvatore Cocuzza; Carmelo Fabiano; Pietro Sammarco; Francesco Martines
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-28       Impact factor: 2.503

9.  Contribution of GJB2 mutations to hearing loss in the Hazara Division of Pakistan.

Authors:  Ihtisham Bukhari; Ghulam Mujtaba; Sadaf Naz
Journal:  Biochem Genet       Date:  2013-03-17       Impact factor: 1.890

10.  Deafness induced by Connexin 26 (GJB2) deficiency is not determined by endocochlear potential (EP) reduction but is associated with cochlear developmental disorders.

Authors:  Jin Chen; Jing Chen; Yan Zhu; Chun Liang; Hong-Bo Zhao
Journal:  Biochem Biophys Res Commun       Date:  2014-04-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.